Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of IVR and CATI Surveys in Bangladesh

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04508010
Recruitment Status : Recruiting
First Posted : August 11, 2020
Last Update Posted : March 23, 2021
Sponsor:
Collaborator:
Institute of Epidemiology, Disease Control and Research
Information provided by (Responsible Party):
Johns Hopkins Bloomberg School of Public Health

Brief Summary:
This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and computer assisted telephone interviews (CATI) surveys conducted in low-and middle-income (LMIC) setting (Bangladesh) and evaluates how the two survey modalities (IVR and CATI) affect survey metrics, including response, completion and attrition rates.

Condition or disease Intervention/treatment Phase
Surveys and Questionnaires Non Communicable Diseases Other: IVR Other: CATI Not Applicable

Detailed Description:
Using random digit dialing (RDD) sampling technique, participants will be randomized to one of two arms : 1) IVR or 2) CATI. Participants in the first study arm will receive an IVR survey. Participants in the second study arm will receive a CATI survey. Each questionnaire contains a set of demographic questions and one non-communicable disease (NCD) module (alcohol, or tobacco, or diet, or physical activity, or blood pressure and diabetes). We will examine contact, response, refusal and cooperation rates and demographic representativeness by each study arm.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 6160 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Masking Description: Data cleaning and analysis will be conducted by a statistician blinded to the study arm
Primary Purpose: Other
Official Title: Comparison of Interactive Voice Response (IVR) and Computer-assisted Telephone Interview (CATI) Mobile Phone Surveys for Non-communicable Disease Risk Factor Surveillance in Bangladesh
Actual Study Start Date : August 25, 2020
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2021

Arm Intervention/treatment
Experimental: IVR survey
Participants will receive an IVR survey
Other: IVR
Participants will receive an IVR survey

Experimental: CATI survey
Participants will receive a CATI survey
Other: CATI
Participants will receive a CATI survey




Primary Outcome Measures :
  1. Cooperation Rate #1 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs

  2. Response Rate #4 [ Time Frame: Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns


Secondary Outcome Measures :
  1. Contact Rate #2 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns

  2. Refusal Rate #2 [ Time Frame: Through study completion, an average of one month ]
    As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in Bengali language

Exclusion Criteria:

  • Less than 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04508010


Contacts
Layout table for location contacts
Contact: Vidhi Maniar, MPH 4106144730 vmaniar1@jh.edu
Contact: Dustin Gibson, PhD 4432878763 dgibso28@jhu.edu

Locations
Layout table for location information
Bangladesh
Institute of Epidemiology, Disease Control and Research Recruiting
Dhaka, Bangladesh
Contact: Iqbal Khan, PhD         
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
Institute of Epidemiology, Disease Control and Research
Investigators
Layout table for investigator information
Principal Investigator: Dustin Gibson, PhD Johns Hopkins University Bloomberg School of Public Health
Principal Investigator: Iqbal Khan, PhD Institute of Epidemiology, Disease Control and Research
Publications:
Layout table for additonal information
Responsible Party: Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier: NCT04508010    
Other Study ID Numbers: 00007318 - Bangladesh
First Posted: August 11, 2020    Key Record Dates
Last Update Posted: March 23, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Johns Hopkins Bloomberg School of Public Health:
mobile phone surveys
interactive voice response
Additional relevant MeSH terms:
Layout table for MeSH terms
Noncommunicable Diseases
Disease Attributes
Pathologic Processes